OTC Markets OTCQB - Delayed Quote USD
Nymox Pharmaceutical Corporation (NYMXF)
0.1178
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,781
-4,057
-5,205
-9,820
-10,037
Investing Cash Flow
--
-3
--
-6
-13
Financing Cash Flow
2,746
2,727
5,778
7,045
8,422
End Cash Position
2,707
-70
-1,403
-830
3,611
Capital Expenditure
--
-3
--
-6
-13
Issuance of Capital Stock
2,005
1,150
6,007
7,283
8,687
Repayment of Debt
-9
-173
-229
-238
-265
Free Cash Flow
-2,781
-4,060
-5,205
-9,826
-10,050
12/31/2020 - 11/26/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0300
0.00%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
LEXXW Lexaria Bioscience Corp.
0.2853
-16.09%
ATNFW 180 Life Sciences Corp.
0.0077
0.00%
MLECW Moolec Science SA
0.0170
+65.05%
IMTXW Immatics N.V.
0.0184
+47.20%
GOVXW GeoVax Labs, Inc.
0.0300
-0.33%
KTTAW Pasithea Therapeutics Corp.
0.0166
-2.35%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%